These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 2140670)

  • 1. Treatment-resistant alopecia areata. Response to combination therapy with minoxidil plus anthralin.
    Fiedler VC; Wendrow A; Szpunar GJ; Metzler C; DeVillez RL
    Arch Dermatol; 1990 Jun; 126(6):756-9. PubMed ID: 2140670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of oral minoxidil in the treatment of alopecia areata.
    Fiedler-Weiss VC; Rumsfield J; Buys CM; West DP; Wendrow A
    Arch Dermatol; 1987 Nov; 123(11):1488-90. PubMed ID: 3674909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of pediatric alopecia areata with anthralin: A retrospective study of 37 patients.
    Wu SZ; Wang S; Ratnaparkhi R; Bergfeld WF
    Pediatr Dermatol; 2018 Nov; 35(6):817-820. PubMed ID: 30338548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of anthralin in the treatment of alopecia areata.
    Fiedler-Weiss VC; Buys CM
    Arch Dermatol; 1987 Nov; 123(11):1491-3. PubMed ID: 3314718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alopecia areata treated with topical minoxidil.
    Weiss VC; West DP; Fu TS; Robinson LA; Cook B; Cohen RL; Chambers DA
    Arch Dermatol; 1984 Apr; 120(4):457-63. PubMed ID: 6703751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic steroids with or without 2% topical minoxidil in the treatment of alopecia areata.
    Olsen EA; Carson SC; Turney EA
    Arch Dermatol; 1992 Nov; 128(11):1467-73. PubMed ID: 1444500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of anthralin in combination with diphenylcyclopropenone in the treatment of alopecia areata: a retrospective case series.
    Nasimi M; Ghandi N; Abedini R; Mirshamsi A; Shakoei S; Seirafi H
    Arch Dermatol Res; 2019 Oct; 311(8):607-613. PubMed ID: 31165933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical minoxidil in the treatment of alopecia areata.
    Fenton DA; Wilkinson JD
    Br Med J (Clin Res Ed); 1983 Oct; 287(6398):1015-7. PubMed ID: 6412929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of diphenylcyclopropenone alone or in combination with anthralin in the treatment of chronic extensive alopecia areata: a retrospective case series.
    Durdu M; Özcan D; Baba M; Seçkin D
    J Am Acad Dermatol; 2015 Apr; 72(4):640-50. PubMed ID: 25653027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical minoxidil. A preliminary review of its pharmacodynamic properties and therapeutic efficacy in alopecia areata and alopecia androgenetica.
    Clissold SP; Heel RC
    Drugs; 1987 Feb; 33(2):107-22. PubMed ID: 3552591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical minoxidil for hair regrowth.
    Vanderveen EE; Ellis CN; Kang S; Case P; Headington JT; Voorhees JJ; Swanson NA
    J Am Acad Dermatol; 1984 Sep; 11(3):416-21. PubMed ID: 6384289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical minoxidil solution (1% and 5%) in the treatment of alopecia areata.
    Fiedler-Weiss VC
    J Am Acad Dermatol; 1987 Mar; 16(3 Pt 2):745-8. PubMed ID: 3549811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical minoxidil dose-response effect in alopecia areata.
    Fiedler-Weiss VC; West DP; Buys CM; Rumsfield JA
    Arch Dermatol; 1986 Feb; 122(2):180-2. PubMed ID: 3947124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Higher concentrations of dithranol appear to induce hair growth even in severe alopecia areata.
    Ngwanya MR; Gray NA; Gumedze F; Ndyenga A; Khumalo NP
    Dermatol Ther; 2017 Jul; 30(4):. PubMed ID: 28598005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hair regrowth. Therapeutic agents.
    Shapiro J; Price VH
    Dermatol Clin; 1998 Apr; 16(2):341-56. PubMed ID: 9589208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of chronic extensive alopecia areata by diphenylcyclopropenone alone versus in combination with anthralin.
    Ibrahim SA; Esawy AM; Abdelshafy AS
    Dermatol Ther; 2019 Sep; 32(5):e13010. PubMed ID: 31237076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The therapeutic use of topical minoxidil.
    DeVillez RL
    Dermatol Clin; 1990 Apr; 8(2):367-75. PubMed ID: 2191807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extensive alopecia areata. Results of treatment with 3% topical minoxidil.
    Ranchoff RE; Bergfeld WF; Steck WD; Subichin SJ
    Cleve Clin J Med; 1989; 56(2):149-54. PubMed ID: 2659203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anthralin therapy for alopecia areata.
    Nelson DA; Spielvogel RL
    Int J Dermatol; 1985 Nov; 24(9):606-7. PubMed ID: 3905640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical minoxidil (3%) in extensive alopecia areata, including long-term efficacy.
    Price VH
    J Am Acad Dermatol; 1987 Mar; 16(3 Pt 2):737-44. PubMed ID: 3549810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.